A semi-synthetic approach to treat tuberculosis

NIAID [Public domain] via Wikimedia Commons

Tuberculosis, caused by infection with Mycobacterium tuberculosis, is a leading cause of illness and death worldwide, killing >1 million people annually. Current treatment uses multiple drugs, lasts for months and is challenged by increasing drug resistance among strains. Mycobacterial drug resistance is mediated in part by efflux, a pumping mechanism that sheds drugs from the bacterial cell before they take effect. In the search for new, effective treatments for tuberculosis, a team of researchers used structure-based design to generate semi-synthetic antimicrobial compounds with narrow-spectrum activity against mycobacteria.

Lab Anim. (NY) 43, 74 (2014).
view full text (login required)
Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: